CM&R HMO Research Network 2008 conference proceedings and abstracts NOW ONLINE!
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Medicine & Research
Volume , Number :
doi:
© 2009 Marshfield Clinic
Right arrow Return to article

Table 1. Approximate oral equianalgesic doses.
Opioid Equianalgesic Oral Dose (mg) Dosing Interval (hours)

meperidine (Demerol*) 300 2–3
codeine 200 3–4
morphine 30 3–4
oxycodone IR (Roxicodone*, Also in Percocet*, Percodan*, Tylox*, others) 20–30 3–4
Avinza* 30 24
oxycodone SR 30 8–12
methadone (Dolophine*, others) 20 6–8
levorphanol (levo-dromoran) 4 6–8
hydromorphone (Dilaudid*) 7.5 3–4
fentanyl (Duragesic Trans-dermal System*) 25 mcg/hr 72


*Demerol (Sanofi-Synthelabo, Malvern, PA); Roxicodone and Dolophine (Roxane Laboratories, Inc. Columbus, OH); Percocet and Percodan (Endo Pharmaceuticals Inc., Chadds Ford, PA); Tylox (Ortho-McNeil Pharmaceutical, Raritan, NJ); Avinza (Ligand Pharmaceuticals, San Diego, CA); Dilaudid (Abbott Laboratories, Chicago, IL); Fentanyl Transdermal System (Janssen Pharmaceutica, Inc., Titusville, NJ).





Right arrow Return to article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS